ATE329582T1 - Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit - Google Patents

Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit

Info

Publication number
ATE329582T1
ATE329582T1 AT02727807T AT02727807T ATE329582T1 AT E329582 T1 ATE329582 T1 AT E329582T1 AT 02727807 T AT02727807 T AT 02727807T AT 02727807 T AT02727807 T AT 02727807T AT E329582 T1 ATE329582 T1 AT E329582T1
Authority
AT
Austria
Prior art keywords
microcrystalline cellulose
tablets
pharmaceutically active
unfavorable
production
Prior art date
Application number
AT02727807T
Other languages
English (en)
Inventor
Pal Fekete
Ignacz Maria Kiralyne
Szell Zsuzsa Szlavyne
Laszlone Gora
Zoltanne Palfi
Istvanne Jambor
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29287270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE329582(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of ATE329582T1 publication Critical patent/ATE329582T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
AT02727807T 2002-04-29 2002-04-29 Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit ATE329582T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU2002/000035 WO2003092658A1 (en) 2002-04-29 2002-04-29 A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose

Publications (1)

Publication Number Publication Date
ATE329582T1 true ATE329582T1 (de) 2006-07-15

Family

ID=29287270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727807T ATE329582T1 (de) 2002-04-29 2002-04-29 Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit

Country Status (14)

Country Link
US (1) US20050163836A1 (de)
EP (1) EP1501484B2 (de)
AT (1) ATE329582T1 (de)
AU (1) AU2002258002A1 (de)
CZ (1) CZ296100B6 (de)
DE (1) DE60212464T2 (de)
DK (1) DK1501484T3 (de)
EA (1) EA006008B1 (de)
ES (1) ES2266496T3 (de)
HK (1) HK1073263A1 (de)
PT (1) PT1501484E (de)
SK (1) SK50232004A3 (de)
UA (1) UA75831C2 (de)
WO (1) WO2003092658A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
WO2005011707A1 (en) * 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
NZ549838A (en) * 2004-03-26 2010-04-30 Eisai R&D Man Co Ltd Coated controlled-release preparation containing a gastric acid secretion inhibitor
EP1930030A1 (de) * 2005-09-29 2008-06-11 Eisai R&D Management Co., Ltd. Puls-präparat mit verbesserten zerfallseigenschaften in vivo
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US20100105738A1 (en) * 2006-10-06 2010-04-29 Mitsuru Mizuno Extended release formulations of a proton pump inhibitor
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
WO2012116434A1 (en) * 2011-03-01 2012-09-07 4413261 Canada Inc. (Spencer Canada) Two speed monolithic system for controlled release of drugs
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
RU2657424C1 (ru) * 2017-02-27 2018-06-13 Павел Владимирович Алексенко Способ производства таблеток

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146168A (en) † 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
US4543332A (en) * 1982-03-29 1985-09-24 Miles Laboratories, Inc. Method for the preparation of spherical microorganism cell aggregates
US5073380A (en) * 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4911921A (en) † 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
ATE171838T1 (de) † 1991-01-16 1998-10-15 Fmc Corp Träger für wirkstoffe und damit hergestellte feste darreichungsformen
HU214588B (hu) † 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
JPH11506473A (ja) * 1997-02-25 1999-06-08 ザ、プロクター、エンド、ギャンブル、カンパニー 湿式粒状化方法
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics

Also Published As

Publication number Publication date
EP1501484B2 (de) 2010-07-07
PT1501484E (pt) 2006-10-31
HK1073263A1 (en) 2005-09-30
SK50232004A3 (sk) 2005-04-01
WO2003092658A1 (en) 2003-11-13
US20050163836A1 (en) 2005-07-28
ES2266496T3 (es) 2007-03-01
EA200401418A1 (ru) 2005-04-28
CZ20041145A3 (cs) 2005-03-16
UA75831C2 (en) 2006-05-15
DK1501484T3 (da) 2006-10-23
DE60212464D1 (de) 2006-07-27
EA006008B1 (ru) 2005-08-25
EP1501484A1 (de) 2005-02-02
CZ296100B6 (cs) 2006-01-11
AU2002258002A1 (en) 2003-11-17
EP1501484B1 (de) 2006-06-14
DE60212464T2 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
HK1073263A1 (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose
WO2001078725A3 (en) Modified release formulations containing a hypnotic agent
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
SI2821067T1 (en) Quick spray formulation of cinacalcet
AU1531199A (en) Pharmaceutical suspension tablet compositions
HUP0001329A2 (hu) Szétesést elősegítő anyag tömörített granulátuma tablettákhoz, eljárás előállítására, valamint alkalmazása
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
CA2330480A1 (en) Controlled release formulation of divalproex sodium
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
CA2301132A1 (en) Rapidly disintegrating methylcellulose tablets
RU2010101797A (ru) Фармацевтический твердый препарат, содержащий бензазепины и способ его получения
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
ATE441410T1 (de) Fenofibrattabletten
WO2005004849A3 (en) Pharmaceutical formulation comprising levothyroxine sodium
SE8901003D0 (sv) Snabbloesliga preparat
WO2004000265A3 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
RS51578B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина
IL182549A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
BG108956A (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising macrocrystalline cellulose
ATE526961T1 (de) Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
WO2004078108A3 (fr) Comprime de fenofibrate et procede de fabrication
RS54304A (en) Amlodipine bezylate tabletes with improved stability
KR900009060A (ko) 트리메부틴 기재 서방형 조성물 및 그 제조 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1501484

Country of ref document: EP

REN Ceased due to non-payment of the annual fee